Coherus Oncology Inc (CHRS)

Depreciation & Amortization

$3.61M

TTM · Period ending: · USD

CHRS logo

CHRS Depreciation & Amortization

Latest reported$3.61M
CHRS TTM Depreciation & Amortization ($404.00K → $3.61M)
High-resolution chart · PNG

CHRS depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
3,605,000
3,759,000
3,924,000
4,061,000
4,644,000
4,815,000
5,276,000
5,306,000
4,656,000
4,349,000
3,791,000
3,778,000
3,874,000
3,881,000
3,699,000
4,074,000
3,971,000
3,961,000
4,043,000
3,458,000
3,259,000
3,130,000
2,888,000
3,103,000
3,249,000
3,175,000
3,259,000
2,817,000
2,776,000
3,004,000
3,235,000
3,548,000
3,520,000
3,455,000
3,398,000
3,269,000
3,252,000
3,144,000
2,996,000
2,800,000
2,683,000
2,354,000
1,869,000
1,503,000
1,059,000
790,000
674,000
547,000
456,000
424,000
404,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.